148 related articles for article (PubMed ID: 37612257)
21. β-Catenin Signaling Regulates the
Tarnow G; McLachlan A
J Virol; 2021 Sep; 95(20):e0078021. PubMed ID: 34319157
[TBL] [Abstract][Full Text] [Related]
22. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
23. Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion.
Wong AM; Ding X; Wong AM; Xu M; Zhang L; Leung HH; Chan AW; Song QX; Kwong J; Chan LK; Man M; He M; Chen J; Zhang Z; You W; Lau C; Yu A; Wei Y; Yuan Y; Lai PB; Zhao J; Man K; Yu J; Kahn M; Wong N
J Hepatol; 2022 Aug; 77(2):410-423. PubMed ID: 35351523
[TBL] [Abstract][Full Text] [Related]
24. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
25. Forced activation of β-catenin signaling supports the transformation of hTERT-immortalized human fetal hepatocytes.
Wege H; Heim D; Lütgehetmann M; Dierlamm J; Lohse AW; Brümmendorf TH
Mol Cancer Res; 2011 Sep; 9(9):1222-31. PubMed ID: 21807967
[TBL] [Abstract][Full Text] [Related]
26. Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen.
Rignall B; Braeuning A; Buchmann A; Schwarz M
Carcinogenesis; 2011 Jan; 32(1):52-7. PubMed ID: 21047994
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic Mutations in Armadillo Repeats 5 and 6 of β-Catenin Reduce Binding to APC, Increasing Signaling and Transcription of Target Genes.
Liu P; Liang B; Liu M; Lebbink JHG; Li S; Qian M; Lavrijsen M; Peppelenbosch MP; Chen X; Smits R
Gastroenterology; 2020 Mar; 158(4):1029-1043.e10. PubMed ID: 31857074
[TBL] [Abstract][Full Text] [Related]
28. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP
J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204
[TBL] [Abstract][Full Text] [Related]
29. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.
Harada N; Oshima H; Katoh M; Tamai Y; Oshima M; Taketo MM
Cancer Res; 2004 Jan; 64(1):48-54. PubMed ID: 14729607
[TBL] [Abstract][Full Text] [Related]
30. β-Catenin signaling in hepatocellular carcinoma.
Xu C; Xu Z; Zhang Y; Evert M; Calvisi DF; Chen X
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166233
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β-Catenin in Mice.
Liu Y; Cao L; Chen R; Zhou X; Fan X; Liang Y; Jia R; Wang H; Liu G; Guo Y; Zhao J
Stem Cells; 2015 Dec; 33(12):3569-80. PubMed ID: 26033745
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
[TBL] [Abstract][Full Text] [Related]
33. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
[TBL] [Abstract][Full Text] [Related]
34. Selective effect of β-catenin on nuclear receptor-dependent hepatitis B virus transcription and replication.
Tarnow G; McLachlan A
Virology; 2022 Jun; 571():52-58. PubMed ID: 35509137
[TBL] [Abstract][Full Text] [Related]
35. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
[TBL] [Abstract][Full Text] [Related]
36. Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.
Laohapand C; Arromdee E; Tanwandee T
Hepatol Int; 2015 Apr; 9(2):202-8. PubMed ID: 25788188
[TBL] [Abstract][Full Text] [Related]
37. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
[TBL] [Abstract][Full Text] [Related]
38. C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling.
Lee S; Lee MJ; Zhang J; Yu GR; Kim DG
Exp Mol Med; 2016 Dec; 48(12):e275. PubMed ID: 27909336
[TBL] [Abstract][Full Text] [Related]
39. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
[TBL] [Abstract][Full Text] [Related]
40. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]